Metabolites were identified and quantified using liquid chromatographymass spectrometry (LC-MS)
Any use in humans or animals is strictly prohibited and may violate federal, state, or local laws, including the Federal Food, Drug, and Cosmetic Act
Coenzyme cellular energy IV/SubQ 100500 mg Mitochondrial-derived peptide preclinical 35x weekly 510 mg Mitochondrial-derived peptide preclinical no approved human dose Mitochondria-targeting peptide FDA-approved only for Barth syndrome daily 440 mg AEDG tetrapeptide bioregulator research-use 1020 day cycles Senolytic peptide preclinical only no validated human dose Endogenous antioxidant oral/liposomal/IV context 2501,000 mg oral study range MC receptor agonist preclinical loading + maintenance 250500 mcg Also listed under Repair skin remodeling topical/SubQ 12 mg Sexual Health & Hormonal Peptides studied for sexual response and hormonal pathways
We do not publish reconstitution steps publicly, because errors carry real safety risks and the process should be calibrated to a specific prescription
How Researchers Describe Its Mechanism In research settings, AOD 9604 has been studied for its proposed role in lipolysis, the breakdown of stored fat
